Filing Details
- Accession Number:
- 0001144204-12-051701
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-17 17:02:55
- Reporting Period:
- 2012-09-13
- Filing Date:
- 2012-09-17
- Accepted Time:
- 2012-09-17 16:02:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1138776 | Medgenics Inc. | MDGN | Biological Products, (No Disgnostic Substances) (2836) | 980217544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1516544 | Andrew Pearlman | 555 California Street, Suite 365 San Francisco CA 94104 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-09-13 | 19,623 | $10.66 | 48,562 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-09-14 | 4,000 | $10.73 | 44,562 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 94 | Indirect | By Spouse |
| Common Stock | 1,719 | Indirect | By ADP Holdings LLC |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.27 to $11.05, inclusive. The reporting person undertakes to provide Medgenics, Inc., any security holder of Medgenics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.52 to $11.13, inclusive. The reporting person undertakes to provide Medgenics, Inc., any security holder of Medgenics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
